Zivo Bioscience (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZIVO | AMGN | VRTX | REGN | BMY |
| Company | Zivo Bioscience | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 7.8300 | 314.82 | 430.93 | 988.00 | 45.00 |
| High | 7.9800 | 321.44 | 439.26 | 988.96 | 45.17 |
| Low | 7.8300 | 312.87 | 428.62 | 966.34 | 44.48 |
| Last | 7.9800 | 319.04 | 437.49 | 978.21 | 44.55 |
| Change | +0.1500 | +7.63 | +8.90 | -6.43 | -0.16 |
| % Change | +1.92% | +2.45% | +2.08% | -0.65% | -0.36% |
| Volume | 1,064 | 3,457,602 | 1,055,577 | 588,785 | 13,427,400 |
| 20-Day Average Volume | 1,783 | 2,905,339 | 1,087,281 | 454,231 | 14,082,428 |
| Previous Close | 7.8300 | 311.41 | 428.59 | 984.64 | 44.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.6504 | 288.86 | 407.48 | 931.32 | 45.49 |
| 20-Day Raw Stochastic | 95.01% | 96.33% | 94.98% | 90.94% | 19.69% |
| 20-Day Relative Strength | 51.37% | 69.29% | 68.70% | 61.48% | 35.79% |
| Weighted Alpha | -68.09 | +43.66 | +29.73 | +30.18 | -33.18 |
| Today's Opinion | 40% Buy | 72% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 40% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 64% Buy | 40% Sell | 24% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.40% since 05/07/24 | +4.24% since 05/08/24 | +4.30% since 05/08/24 | +2.39% since 05/08/24 | +2.04% since 05/08/24 |
| Low | 5.6975 on 05/10/24 | 306.32 on 05/09/24 | 416.03 on 05/09/24 | 956.76 on 05/09/24 | 43.49 on 05/09/24 |
| High | 7.9900 on 05/08/24 | 321.44 on 05/15/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | -0.25% since 04/08/24 | +20.65% since 04/15/24 | +9.94% since 04/15/24 | +8.91% since 04/15/24 | -8.14% since 04/15/24 |
| Low | 5.6975 on 05/10/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 8.1000 on 04/29/24 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +14.00% since 02/15/24 | +10.81% since 02/15/24 | +2.47% since 02/15/24 | +2.51% since 02/15/24 | -9.87% since 02/15/24 |
| Low | 5.6975 on 05/10/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 10.2100 on 02/21/24 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +470.00% since 11/15/23 | +17.32% since 11/15/23 | +25.05% since 11/15/23 | +23.51% since 11/15/23 | -13.60% since 11/15/23 |
| Low | 0.4800 on 11/29/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 785.83 on 11/16/23 | 43.33 on 05/02/24 |
| High | 13.0000 on 01/24/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 22,045 | 167,051,216 | 110,598,944 | 108,493,528 | 90,631,640 |
| Shares Outstanding, K | 2,816 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 30,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -7,780,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 10,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -1,910,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.26 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.96 on 03/15/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/15/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.56 | 28.55 | 26.33 | 42.91 |